| Literature DB >> 27144532 |
K Horst1, D Eschbach2, R Pfeifer1, B Relja3, M Sassen4, T Steinfeldt4, H Wulf4, N Vogt5, M Frink2, S Ruchholtz2, H C Pape1, F Hildebrand1.
Abstract
BACKGROUND: Hypothermia has been discussed as playing a role in improving the early phase of systemic inflammation. However, information on the impact of hypothermia on the local inflammatory response is sparse. We therefore investigated the kinetics of local and systemic inflammation in the late posttraumatic phase after induction of hypothermia in an established porcine long-term model of combined trauma. MATERIALS &Entities:
Mesh:
Substances:
Year: 2016 PMID: 27144532 PMCID: PMC4856279 DOI: 10.1371/journal.pone.0154788
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Laboratory parameters.
| 0min | 90min | |||||||
|---|---|---|---|---|---|---|---|---|
| Group | NT-T | NT-S | HT-T | HT-S | NT-T | NT-S | HT-T | HT-S |
| n | 15 | 5 | 15 | 5 | 14 | 5 | 15 | 5 |
| Hb | 92 ±1.9 | 101 ±6.3 | 94 ±1.6 | 94 ±3.0 | 53 ±2.3 | 94 ±2.9 | 49 ±3.3 | 90 ±3.1 |
| p-value | n.s. | n.s. | <0.001 | <0.001 | ||||
| BE | 4.2 ±0.7 | 5.6 ±0.9 | 3.8 ±0.6 | 5.0 ±0.34 | 0.8 ±0.8 | 6.5 ±0.8 | 1.0 ±0.8 | 5.9 ±0.6 |
| p-value | n.s. | n.s. | 0.001 | <0.001 | ||||
| HCO3 | 29.10 ±0.36 | 29.48 ±0.74 | 28.49 ±1.03 | 29.16 ±0.27 | 25.97 ±0.63 | 30.32 ±0.85 | 23.84 ±1.82 | 30.28 ±0.56 |
| p-value | n.s. | n.s. | 0.002 | <0.001 | ||||
| LAC | 0.89 ±0.10 | 1.26 ±0.21 | 1.15 ±0.70 | 0.82 ±0.14 | 3.01 ±0.41 | 1.02 ±0.12 | 2.98 ±0.34 | 0.78 ±0.08 |
| p-value | n.s. | n.s. | 0.001 | <0.001 | ||||
Systemic concentrations of inflammatory parameters (mean value ± SEM): Hb (hemoglobin), BE (base excess), HCO3 (bicarbonate), Lac (lactate); n.s. (not significant)
Serum cytokine & alarmin concentrations (mean value ± SEM); NT-T (normothermic trauma), NT-S (normothermic sham), HT-T (hypothermic trauma), HT-S (hypothermic sham), statistical significance p = <0.05 (a) from sham, b) from baseline, c) NT-T vs. HT-T).
| 0h | 2.5h | 14h | 24h | 48h | ||
|---|---|---|---|---|---|---|
| NT-T | 32.29 ±24.99 | 41.10 ±25.60 | 62. 35 ±38.12 a) b) | 71.95 ±54.76 a) b) | 79.69 ±58.59 a) b) | |
| NT-S | 29.80 ±35.22 | 24.04 ±17.64 | 22.48 ±14.26 | 24.07 ±14.63 | 30.87 ±23.28 | |
| HT-T-S | 42.28 ±14.66 | 41.54 ±24.73 | 82.01 ±47.48 a) b) | 86.23 ±35.93 a) b) | 114.30 ±70.74 b) | |
| HT-S | 40.44 ±2.67 | 52.29 ±5.41b) | 41.71 ±20.31 | 43.22 ±16.75 | 66.29 ±35.37 | |
| NT-T | 156.29 ±32.96 | 140.62 ±41.24 | 148.90 ±25.85 | 161.78 ±32.92 a) | 139.71 ±34.44 | |
| NT-S | 161.72 ±13.50 | 161.58 ±9.96 | 178.99 ±5.01 | 108.90 ±36.92 | 166.29 ±43.33 | |
| HT-T | 168.53 ±38.97 | 163.46 ±19.16 a) | 157.41 ±24.16 a) | 174.79 ±24.97 a) | 181.31 ±42.00 a) c) | |
| HT-S | 181.48 ±10.43 | 227.09 ±27.17 | 311.96 ±193.20 | 259.43 ±32.53 | 230.07 ±24.88 | |
| NT-T | 57.94 ±37.82 | 65.35 ±42.25 | 64.56 ±41.83 | 64.55 ±37.31 | 59.50 ±30.24 | |
| NT-S | 76.54 ±38.79 | 82.69 ±47.93 | 77.45 ±45.21 | 76.22 ±32.22 | 78.58 ±41.04 | |
| HT-T | 37.99 ±38.90 | 46.19 ±25.87 | 50.41 ±33.99 a) | 69.53 ±61.40 b) | 72.37 ±69.29 b) | |
| HT-S | 38.50 ±4.50 c) | 70.28 ±15.6 b) | 82.52 ±24.33 b) | 98.65 ±38.27 b) | 106.38 ±50.08 b) | |
| NT-T | 1.25 ±0.87 | 2.53 ±1.58 a) b) | 2.20 ±1.54 | 4.80 ±3.94 a) b) | 3.01 ±3.21 | |
| NT-S | 0.54 ±0.61 | 0.45 ±0.26 | 1.40 ±0.65 | 1.08 ±0.53 | 1.77 ±0.35 | |
| HT-T | 1.54 ±1.23 | 3.83 ±1.19 a) b) | 3.70 ±2.56 | 4.81 ±2.49 a) b) | 4.73 ±2.30 a) b) c) | |
| HT-S | 1.78 ±0.88 | 1.73 ±0.49 | 1.63 ±1.33 | 1.22 ±0.91 | 1.46 ±1.17 | |
| NT-T | 87.75 ±59.08 | 54.21 ±45.71a) b) | 47.04 ±40.07 a) b) | 56.06 ±42.95 b) | 75.96 ±59.36 | |
| NT-S | 129.92 ±47.00 | 131.04 ±33.52 | 110.19 ±34.71 | 83.89 ±19.63 | 79.14 ±36.73 | |
| HT-T | 50.74 ±39.73 | 31.95 ±37.48 b) | 18.98 ±21.05 b) c) | 16.03 ±14.53 b) c) | 11.51 ±9.79 b) c) | |
| HT-S | 53.37 ±32.71 | 54.95 ±40.98 | 49.92 ±39.50 | 42.27 ±39.79 | 32.63 ±34.96 b) |
Serum & fracture hematoma concentrations.
| 14h | 24h | 48h | |||||
|---|---|---|---|---|---|---|---|
| NT | HT | NT | HT | NT | HT | ||
| serum | 62. 35 ±38.12 | 82.01 ±47.48 | 71.95 ±54.76 | 86.23 ±35.93 | 79.69 ±58.59 | 114.30 ±70.74 | |
| hematoma | 3631.65 ±2992.31 | 5498.08 ±2497.62 | 2725.91 ±2370.57 | 5456.53 ±3091.76 | 1120.99 ±1561.31 | 4142.74 ±2377.71 | |
| serum | 148.90 ±25.85 | 157.07 ±25.11 | 161.78 ±32.92 | 174.79 ±24.97 | 139.71 ±34.44 | 181.31 ±42.00 | |
| hematoma | 658.29 ±84.11 | 370.37 ±94.68 | 676.30 ±181.66 | 379.12 ±82.11 | 877.69 ±491.47 | 394.07 ±115.71 | |
| serum | 64.56 ±41.83 | 50.41 ±33.99 | 64.55 ±37.31 | 69.53 ±61.40 | 59.50 ±30.24 | 72.37 ±69.29 | |
| hematoma | 245.57 ±131.97 | 345.10 ±344.49 | 262.10 ±163.15 | 264.57 ±269.27 | 271.47 ±193.26 | 219.21 ±178.53 | |
| serum | 2.20 ±1.54 | 3.70 ±2.56 | 4.80 ±3.94 | 4.81 ±2.49 | 3.01 ±3.21 | 4.73 ±2.30 | |
| hematoma | 573.50 ±504.35 | 593.75 ±303.66 | 351.89 ±152.79 | 594.62 ±158.86 | 246.79 ±135.00 | 504.95 ±212.52 | |
| serum | 47.04 ±40.07 | 18.98 ±21.05 | 56.06 ±42.95 | 16.03 ±14.53 | 75.96 ±59.36 | 11.51 ±9.79 | |
| hematoma | 87.17 ±95.82 | 47.01 ±32.88 | 84.75 ±99.81 | 34.18 ±21.73 | 130.61 ±256.02 | 38.51 ±28.88 | |
(mean value ± SEM); NT (normothermic), HT (hypothermic); statistical significance p = <0.05
a) from systemic concentrations,
b) from baseline,
c) NT-T vs. HT-T
Fig 1Local IL-6 concentrations.
Statistical significance p = <0.05 (* from baseline, § NT-T vs. HT-T).
Fig 2Local IL-10 concentrations.
Statistical significance p = <0.05 (* from baseline).
Fig 3Local HMBG1 concentrations.
Statistical significance p = <0.05 (* from baseline, § NT-T vs. HT-T).